Clinical Study of Unani Formulation and Terbinafine in the Treatment of Ringworm
Phase 2
- Conditions
- Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
- Registration Number
- CTRI/2020/05/025361
- Lead Sponsor
- Central Council for Research in Unani Medicine New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Clinically diagnosed patients of Quba (confirmed on Direct Microscopy).
-Irrespective of gender
-Patients in the age group of 15 to 65 years.
-Patients ready to participate in the study and ready to follow in instructions & voluntary written consent
Exclusion Criteria
-Patients below and above the age of 15 and 65 years respectively.
-Patient suffering from concomitant diseases like psoriasis & Eczema.
-Patient suffering from severe systemic and metabolic diseases.
-Diabetic, HTN, COPD, Thyrotoxicosis etc and HIV patient.
-Impaired organ functions
-Patients with any trauma and accidents
-Pregnant & Lactating Women.
-Any of them not covered under inclusive criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method